Demethylase FTO enhances the PI3K/Akt signaling to promote gastric cancer malignancy

[1]  Chunye Zhang,et al.  Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer , 2022, Frontiers in Oncology.

[2]  G. Duan,et al.  Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15 , 2022, Frontiers in Cell and Developmental Biology.

[3]  Abdulrahim A. Sajini,et al.  FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms , 2022, International journal of molecular sciences.

[4]  Yu Wang,et al.  N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma , 2022, Frontiers in Oncology.

[5]  Yingting Liu,et al.  N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics , 2022, Cell death & disease.

[6]  Yingting Liu,et al.  N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m6A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics , 2021, Cell Death & Disease.

[7]  Ce Li,et al.  N6-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1 , 2021, Frontiers in Oncology.

[8]  Jiwei Yu,et al.  Prognostic and Predictive Value of m6A “Eraser” Related Gene Signature in Gastric Cancer , 2021, Frontiers in Oncology.

[9]  Song Liu,et al.  Apolipoprotein C‐II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway , 2021, Clinical and translational medicine.

[10]  K. Lam,et al.  ORAI2 Promotes Gastric Cancer Tumorigenicity and Metastasis through PI3K/Akt Signaling and MAPK-Dependent Focal Adhesion Disassembly , 2020, Cancer Research.

[11]  Xiaoyuan Yi,et al.  Exosome-transferred LINC01559 promotes the progression of gastric cancer via PI3K/AKT signaling pathway , 2020, Cell Death & Disease.

[12]  A. Alzahrani.  PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. , 2019, Seminars in cancer biology.

[13]  Xiaoyu Chen,et al.  The role of m6A RNA methylation in human cancer , 2019, Molecular Cancer.

[14]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[15]  Yu Zhang,et al.  m6A facilitates hippocampus-dependent learning and memory through Ythdf1 , 2018, Nature.

[16]  Chuan He,et al.  m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer , 2018, Nature Cell Biology.

[17]  Ying Jin,et al.  m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. , 2018, Biochemical and biophysical research communications.

[18]  Juan Wu,et al.  miR-589 promotes gastric cancer aggressiveness by a LIFR-PI3K/AKT-c-Jun regulatory feedback loop , 2018, Journal of Experimental & Clinical Cancer Research.

[19]  Yongming Chen,et al.  Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer , 2018, BMC Cancer.

[20]  Lai Wei,et al.  RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2 , 2018, Hepatology.

[21]  H. Zhe,et al.  FTO regulates the chemo‐radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β‐catenin through mRNA demethylation , 2018, Molecular carcinogenesis.

[22]  R. Deng,et al.  SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function , 2018, Nucleic acids research.

[23]  Yue Sheng,et al.  METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. , 2017, Cell stem cell.

[24]  Hui Liu,et al.  LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway , 2017, Journal of experimental & clinical cancer research : CR.

[25]  Stefan Canzar,et al.  Temporal Control of Mammalian Cortical Neurogenesis by m6A Methylation , 2017, Cell.

[26]  Y. Liu,et al.  FTO expression is associated with the occurrence of gastric cancer and prognosis. , 2017, Oncology reports.

[27]  Zhike Lu,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[28]  Zhike Lu,et al.  m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.

[29]  Chuan He,et al.  FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.

[30]  Zhen Zhang,et al.  The patterns and timing of recurrence after curative resection for gastric cancer in China , 2016, World Journal of Surgical Oncology.

[31]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[32]  Erez Y. Levanon,et al.  m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation , 2015, Science.

[33]  Chuan He,et al.  FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis , 2014, Cell Research.